journal article·2015-04

Modulation of mesenchymal stem cell behavior by nano- and micro-sized β-tricalcium phosphate particles in suspension and composite structures

Mollie Smoak, Katie Hogan, Lisa Kriegh, Cong Chen, LeKeith B. Terrell, Ammar T. Qureshi, W. Todd Monroe, Jeffrey M. Gimble, Daniel J. Hayes

Journal of Nanoparticle Research· Volume 17· Issue 4
Publisher page

Abstract

Interest has grown in the use of microparticles and nanoparticles for modifying the mechanical and biological properties of synthetic bone composite structures. Micro- and nano-sized calcium phosphates are of interest for their osteoinductive behavior. Engineered composites incorporating polymers and ceramics, such as poly-l-lactic acid (PLLA) and beta-tricalcium phosphate (β-TCP), for bone tissue regeneration have been well investigated for their proliferative and osteoinductive abilities. Only limited research has been done to investigate the effects of different sizes of β-TCP particles on human mesenchymal stromal cell behavior. As such, the aim of this study was to investigate the modulations of human adipose-derived stem cell (hASCs) behavior within cell/particle and cell/composite systems as functions of particle size, concentration, and exposure time. The incorporation of nanoscale calcium phosphate resulted in improved mechanical properties and osteogenic behavior within the scaffold compared to the microscale calcium phosphate additives. Particle exposure results indicate that cytotoxicity on hASCs correlates inversely with particle size and increases with the increasing exposure time and particle concentration. Composites with increasing β-TCP content, whether microparticles or nanoparticles, were less toxic than colloidal micro- and nano-sized β-TCP particles directly supplied to hASCs. The difference in viability observed as a result of varying exposure route is likely related to the increased cell–particle interactions in the direct exposure compared to the particles becoming trapped within the scaffold/polymer matrix.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (42)

Show source-provided references
1. Ambard AJ, Mueninghoff L (2006) Calcium phosphate cement: review of mechanical and biological properties. J Prosthodont 15(5):321–328. doi: 10.1111/j.1532-849X.2006.00129.x10.1111/j.1532-849X.2006.00129.x ↗
2. Aubin J (2001) Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2(1):81–94. doi: 10.1023/A:101001120906410.1023/A:1010011209064 ↗
3. Aunoble S, Clément D, Frayssinet P, Harmand MF, Le Huec JC (2006) Biological performance of a new β-TCP/PLLA composite material for applications in spine surgery: in vitro and in vivo studies. J Biomed Mater Res, Part A 78A(2):416–422. doi: 10.1002/jbm.a.3074910.1002/jbm.a.30749 ↗
4. Bastioli C (ed) (2005) Handbook of biodegradable polymers. Rapra Technology Ltd, Shawbury
5. Blaker J, Maquet V, Jerome R, Boccaccini A, Nazhat S (2005) Mechanical properties of highly porous PDLLA/Bioglass composite foams as scaffolds for bone tissue engineering. Acta Biomater 1(6):643–652. doi: 10.1016/j.actbio.2005.07.00310.1016/j.actbio.2005.07.003 ↗
6. Chai C, Leong KW (2007) Biomaterials approach to expand and direct differentiation of stem cells. Mol Ther 15(3):467–48010.1038/sj.mt.6300084 ↗
7. Charles-Harris M, Koch MA, Navarro M, Lacroix D, Engel E, Planell JA (2008) A PLA/calcium phosphate degradable composite material for bone tissue engineering: an in vitro study. J Mater Sci 19(4):1503–1513. doi: 10.1007/s10856-008-3390-9
8. Chen C, Garber L, Smoak M, Fargason C, Scherr T, Blackburn C, Hayes DJ (2014) In vitro and In vivo characterization of pentaerythritol triacrylate-co-trimethylolpropane nanocomposite scaffolds as potential bone augments and grafts. Tissue Eng Part A. doi: 10.1089/ten.tea.2014.0018
9. Chou Y-F, Chiou W-A, Xu Y, Dunn JCY, Wu BM (2004) effect of pH on the structural evolution of accelerated biomimetic apatite. Biomaterials 25(22):5323–5331. doi: 10.1016/j.biomaterials.2003.12.03710.1016/j.biomaterials.2003.12.037 ↗
10. El-Ghannam AR (2004) Advanced bioceramic composite for bone tissue engineering: design principles and structure–bioactivity relationship. J Biomed Mater Res 69A:490–50110.1002/jbm.a.30022 ↗
11. Garber L, Chen C, Kilchrist KV, Bounds C, Pojman JA, Hayes D (2013) Thiol-acrylate nanocomposite foams for critical size bone defect repair: a novel biomaterial. J Biomed Mater Res, Part A 101(12):3531–3541. doi: 10.1002/jbm.a.3465110.1002/jbm.a.34651 ↗
12. Gimble JM, Guilak F (2003) Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy (Taylor & Francis Ltd) 5(5):362–36910.1080/14653240310003026 ↗
13. Gunatillake PA, Adhikari R (2003) Biodegradable synthetic polymers for tissue engineering. Eur Cells Mater 5:1–1610.22203/eCM.v005a01 ↗
14. Haaparanta A-M, Haimi S, Ellä V, Hopper N, Miettinen S, Suuronen R, Kellomäki M (2010) Porous polylactide/β-tricalcium phosphate composite scaffolds for tissue engineering applications. J Tissue Eng Regen Med 4(5):366–373. doi: 10.1002/term.24910.1002/term.249 ↗
15. Habibovic P, Yuan H, van der Valk CM, Meijer G, van Blitterswijk CA, de Groot K (2005) 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials 26(17):3565–3575. doi: 10.1016/j.biomaterials.2004.09.05610.1016/j.biomaterials.2004.09.056 ↗
16. Hutmacher DW (2000) Scaffolds in tissue engineering bone and cartilage. Biomaterials 21:2529–254310.1016/S0142-9612(00)00121-6 ↗
17. Hutmacher DW, Schantz JT, Lam CXF, Tan KC, Lim TC (2007) State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 1(4):245–260. doi: 10.1002/term.2410.1002/term.24 ↗
18. Ignjatovic N, Ninkov P, Ajdukovic Z, Vasiljevic-Radovic D, Uskokovic D (2007) Biphasic calcium phosphate coated with poly-d, l-lactide-co-glycolide biomaterial as a bone substitute. J Eur Ceram Soc 27:1589–159410.1016/j.jeurceramsoc.2006.04.104 ↗
19. Kamitakahara M, Ohtsuki C, Miyazaki T (2008) Review Paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition. J Biomater Appl 23(3):197–212. doi: 10.1177/088532820809679810.1177/0885328208096798 ↗
20. Kang Y, Yin G, Yuan Q, Yao Y, Huang Z, Liao X, Wang H (2008) Preparation of poly(l-lactic acid)/β-tricalcium phosphate scaffold for bone tissue engineering without organic solvent. Mater Lett 62(12–13):2029–2032. doi: 10.1016/j.matlet.2007.11.01410.1016/j.matlet.2007.11.014 ↗
21. Kilroy GE, Foster SJ, Xiying W, Ruiz J, Sherwood S, Heifetz A, Gimble JM (2007) Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 212(3):702–709. doi: 10.1002/jcp.2106810.1002/jcp.21068 ↗
22. Kim J, Taki K, Nagamine S, Ohshima M (2008) Preparation of poly(L-lactic acid) honeycomb monolith structure by unidirectional freezing and freeze-drying. Chem Eng Sci 63(15):3858–3863. doi: 10.1016/j.ces.2008.04.03610.1016/j.ces.2008.04.036 ↗
23. Kim J-W, Taki K, Nagamine S, Ohshima M (2009) Preparation of porous poly(L-lactic acid) honeycomb monolith structure by phase separation and unidirectional freezing. Langmuir 25(9):5304–531210.1021/la804057e ↗
24. Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small 4(1):26–4910.1002/smll.200700595 ↗
25. Ma PX, Zhang R, Xiao G, Franceschi R (2001) Engineering new bone tissue in vitro on highly porous poly (a-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res 54(2):284–29310.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W ↗
26. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jérôme R (2003) Preparation, characterization, and in vitro degradation of bioresorbable and bioactive composites based on bioglass-filled polylactide foams. J Biomed Mater Res 66A:335–34610.1002/jbm.a.10587 ↗
27. Marino G, Rosso F, Cafiero G, Tortora C, Moraci M, Barbarisi M, Barbaris A (2010) b-Tricalcium phosphate 3D scaffold promote alone osteogenic differentiation of human adipose stem cells: in vitro study. J Mater Sci Mater Med 21:353–36310.1007/s10856-009-3840-z ↗
28. Panetta JN, Gupta MD, Longaker MT (2010) Bone regeneration and repair. Curr Stem Cell Res Ther 5(2):122–128. doi: 10.2174/15748881079126861810.2174/157488810791268618 ↗
29. Qureshi AT, Monroe WT, Dasa V, Gimble JM, Hayes DJ (2013) miR-148b–Nanoparticle conjugates for light mediated osteogenesis of human adipose stromal/stem cells. Biomaterials 34(31):7799–781010.1016/j.biomaterials.2013.07.004 ↗
30. Rezwan K, Chen Q, Blaker J, Boccaccini A (2006) Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27(18):3413–3431. doi: 10.1016/j.biomaterials.2006.01.03910.1016/j.biomaterials.2006.01.039 ↗
31. Roether JA, Boccaccini AR, Hench LL, Maquet V, Gautier S, Jerome R (2002) Development and in vitro characterisation of novel bioresorbable and bioactive composite materials based on polylactide foams and bioglasss for tissue engineering applications. Biomaterials 23:3871–387810.1016/S0142-9612(02)00131-X ↗
32. Schugens C, Maquet V, Grandfils C, Jerome R, Teyssie P (1996) Biodegradable and macroporous polylactide implants for cell transplantation: 1. Preparation of macroporous polylactide supports by solid-liquid phase separation. Polymer 37(6):1027–103810.1016/0032-3861(96)87287-9 ↗
33. Shora L, Guceria S, Wen X, Gandhi M, Sun W (2007) Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials 28:5291–529710.1016/j.biomaterials.2007.08.018 ↗
34. Smoak M, Chen C, Qureshi A, Garber L, Pojman JA, Janes ME, Hayes DJ (2014) Antimicrobial cytocompatible pentaerythritol triacrylate-co-trimethylolpropane composite scaffolds for orthopaedic implants. J Appl Polym Sci. doi: 10.1002/app.41099
35. Sui G, Yang X, Mei F, Hu X, Chen G, Deng X, Ryu S (2007) Poly-L-lactic acid/hydroxyapatite hybrid membrane for bone tissue regeneration. J Biomed Mater Res, Part A 82A(2):445–454. doi: 10.1002/jbm.a.3116610.1002/jbm.a.31166 ↗
36. Sun F, Zhou H, Lee J (2011) Various preparation methods of highly porous hydroxyapatite/polymer nanoscale biocomposites for bone regeneration. Acta Biomater 7(11):3813–3828. doi: 10.1016/j.actbio.2011.07.00210.1016/j.actbio.2011.07.002 ↗
37. Thamaraiselvi TV, Rajeswari S (2004) Biological evaluation of bioceramic materials—a review. Trends Biomater Artif Org 18(1):9–17
38. Uskokovic V, Uskokovic DP (2011) Review: nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents. J Biomed Mater Res Part B: Appl Biomater 96B:152–19110.1002/jbm.b.31746 ↗
39. Wang H, Li Y, Zuo Y, Li J, Ma S, Cheng L (2007) Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering. Biomaterials 28(22):3338–3348. doi: 10.1016/j.biomaterials.2007.04.01410.1016/j.biomaterials.2007.04.014 ↗
40. Wei G, Ma PX (2004) Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials 25:4749–475710.1016/j.biomaterials.2003.12.005 ↗
41. Yu G, Wu X, Dietrich MA, Polk P, Scott LK, Ptitsyn AA, Gimble JM (2010) Yield and characterization of subcutaneous human adipose-derived stem cells by flow cytometric and adipogenic mRNA analyzes. Cytotherapy 12(4):538–546. doi: 10.3109/1465324100364952810.3109/14653241003649528 ↗
42. Zanetti AS, McCandless GT, Chan JY, Gimble JM, Hayes DJ (2013) In vitro human adipose-derived stromal/stem cells osteogenesis in akermanite: poly-ε-caprolactone scaffolds. J Biomater App. doi: 10.1177/0885328213490974